Table 2 Haplotype phasing small variants.
From: An integrated Asian human SNV and indel benchmark established using multiple sequencing methods
Chr | CCS | stLFR | ||||
|---|---|---|---|---|---|---|
Heterozygous | Phased SNV | Phased rate(%) | Heterozygous | Phased SNV | Phased rate(%) | |
1 | 169,906 | 169,174 | 99.57 | 172,790 | 172,682 | 99.94 |
2 | 167,518 | 166,806 | 99.57 | 103,486 | 103,435 | 99.95 |
3 | 143,618 | 142,968 | 99.55 | 101,126 | 101,070 | 99.94 |
4 | 151,585 | 151,033 | 99.64 | 102,317 | 102,274 | 99.96 |
5 | 128,296 | 127,772 | 99.59 | 75,908 | 75,874 | 99.96 |
6 | 131,798 | 131,325 | 99.64 | 70,091 | 70,064 | 99.96 |
7 | 123,689 | 123,253 | 99.65 | 68,411 | 68,379 | 99.95 |
8 | 120,782 | 120,391 | 99.68 | 72,564 | 72,536 | 99.96 |
9 | 94,946 | 94,653 | 99.69 | 53,789 | 53,762 | 99.95 |
10 | 99,256 | 98,894 | 99.64 | 60,279 | 60,254 | 99.96 |
11 | 100,822 | 100,465 | 99.65 | 49,744 | 49,724 | 99.96 |
12 | 101,519 | 101,168 | 99.65 | 172,818 | 172,720 | 99.94 |
13 | 75,515 | 75,282 | 99.69 | 43,553 | 43,531 | 99.95 |
14 | 68,223 | 67,954 | 99.61 | 37,388 | 37,370 | 99.95 |
15 | 67,759 | 67,549 | 99.69 | 34,105 | 34,089 | 99.95 |
16 | 69,062 | 68,823 | 99.65 | 145,073 | 145,017 | 99.96 |
17 | 54,620 | 54,358 | 99.52 | 151,677 | 151,603 | 99.95 |
18 | 59,025 | 58,847 | 99.7 | 130,925 | 130,865 | 99.95 |
19 | 48,314 | 48,195 | 99.75 | 135,438 | 135,376 | 99.95 |
20 | 42,939 | 42,750 | 99.56 | 126,619 | 126,552 | 99.95 |
21 | 39,076 | 39,010 | 99.83 | 122,931 | 122,888 | 99.97 |
22 | 31,029 | 30,979 | 99.84 | 111,751 | 111,697 | 99.95 |
X | — | — | — | 4,418 | 3,636 | 82.3 |
Y | — | — | — | 4,444 | 4,354 | 97.97 |
Genome | 2,089,297 | 2,081,649 | 99.63 | 2,151,645 | 2,149,752 | 99.91 |
